Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Nov;36(5):413-6.
doi: 10.1111/j.1365-2125.1993.tb00389.x.

Distribution of indomethacin in human milk and estimation of its milk to plasma ratio in vitro

L Beaulac-Baillargeon  1 , G Allard
Affiliations

Distribution of indomethacin in human milk and estimation of its milk to plasma ratio in vitro

L Beaulac-Baillargeon et al. Br J Clin Pharmacol. 1993 Nov.

Abstract

1. The distribution of indomethacin in fat and protein fractions of colostrum and mature milk as well as its milk to plasma drug concentration ratio (M/P ratio) were determined in vitro. 2. The extent of plasma protein binding of indomethacin (5-20 microg ml(-1)) was > or = 99.6%. The protein binding of indomethacin in colostrum was 46.0% at pH 7.4. The lower protein content of mature milk compared with colostrum was associated with a significant decrease in the extent of drug protein binding (46 +/- 1.93 to 35 +/- 1.0 s.e. mean). Protein binding was also decreased significantly in 8% fat mature milk (20.3 +/- 2.4 s.e mean) but was constant over the pH range 7.4 to 6.8. 3. About 40% of indomethacin added to milk was associated with the fatty layer. The indomethacin M/P ratio determined by equilibrium dialysis was less than 0.01. Hence the maximum infant daily dose was estimated to be 0.006 mg kg(-1). 4. Our results indicate that indomethacin transfers to milk by simple diffusion according to its physicochemical properties, and that treatment with indomethacin is not a contraindication to breast feeding.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Br J Rheumatol. 1985 Aug;24(3):291-7 - PubMed
    1. Dev Pharmacol Ther. 1980;1(2-3):111-24 - PubMed
    1. J Pharm Sci. 1987 Mar;76(3):189-93 - PubMed
    1. J Pharm Sci. 1988 Sep;77(9):796-8 - PubMed
    1. Pharm Res. 1990 May;7(5):537-41 - PubMed

Publication types

LinkOut - more resources

-